Jane Street’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $31.3M | Sell |
390,333
-201,167
| -34% | -$16.6M | ﹤0.01% | 1407 |
|
|
2025
Q4 | $50.4M | Sell |
591,500
-969,648
| -62% | -$79.6M | 0.01% | 939 |
|
|
2025
Q3 | $121M | Buy |
1,561,148
+1,008,789
| +183% | +$78.8M | 0.02% | 504 |
|
|
2025
Q2 | $43.2M | Buy |
552,359
+84,695
| +18% | +$6.32M | 0.01% | 861 |
|
|
2025
Q1 | $33.9M | Buy |
467,664
+403,863
| +633% | +$28.9M | 0.01% | 918 |
|
|
2024
Q4 | $4.72M | Buy |
63,801
+26,748
| +72% | +$1.87M | ﹤0.01% | 2727 |
|
|
2024
Q3 | $2.45M | Sell |
37,053
-318,569
| -90% | -$23.1M | ﹤0.01% | 4070 |
|
|
2024
Q2 | $32.8M | Buy |
355,622
+206,884
| +139% | +$18.3M | 0.01% | 925 |
|
|
2024
Q1 | $14.2M | Sell |
148,738
-11,822
| -7% | -$993K | ﹤0.01% | 1485 |
|
|
2023
Q4 | $12.2M | Sell |
160,560
-20,736
| -11% | -$1.44M | ﹤0.01% | 1738 |
|
|
2023
Q3 | $12.6M | Buy |
181,296
+82,160
| +83% | +$6.6M | ﹤0.01% | 1536 |
|
|
2023
Q2 | $9.35M | Buy |
99,136
+23,289
| +31% | +$2.02M | ﹤0.01% | 1976 |
|
|
2023
Q1 | $6.27M | Sell |
75,847
-36,449
| -32% | -$2.87M | ﹤0.01% | 2149 |
|
|
2022
Q4 | $8.38M | Sell |
112,296
-27,351
| -20% | -$2.11M | ﹤0.01% | 1819 |
|
|
2022
Q3 | $11.5M | Buy |
139,647
+73,166
| +110% | +$7.04M | 0.01% | 1554 |
|
|
2022
Q2 | $6.32M | Buy |
66,481
+55,624
| +512% | +$5.76M | ﹤0.01% | 2325 |
|
|
2022
Q1 | $1.28M | Sell |
10,857
-16,087
| -60% | -$1.8M | ﹤0.01% | 5611 |
|
|
2021
Q4 | $3.49M | Sell |
26,944
-156,185
| -85% | -$18.2M | ﹤0.01% | 3431 |
|
|
2021
Q3 | $20.7M | Sell |
183,129
-413,249
| -69% | -$47.2M | 0.01% | 1116 |
|
|
2021
Q2 | $61.8M | Buy |
596,378
+481,653
| +420% | +$45.4M | 0.02% | 460 |
|
|
2021
Q1 | $9.6M | Buy |
114,725
+61,133
| +114% | +$5.17M | ﹤0.01% | 1585 |
|
|
2020
Q4 | $4.89M | Buy |
+53,592
| New | +$4.45M | ﹤0.01% | 2161 |
|
|
2020
Q3 | – | Sell |
-7,818
| Closed | -$610K | – | 7330 |
|
|
2020
Q2 | $540K | Sell |
7,818
-138,273
| -95% | -$9.83M | ﹤0.01% | 4972 |
|
|
2020
Q1 | $9.19M | Buy |
146,091
+140,265
| +2,408% | +$10.1M | 0.01% | 816 |
|
|
2019
Q4 | $453K | Sell |
5,826
-14,352
| -71% | -$1.12M | ﹤0.01% | 3806 |
|
|
2019
Q3 | $1.48M | Sell |
20,178
-618,171
| -97% | -$43.4M | ﹤0.01% | 2135 |
|
|
2019
Q2 | $39.3M | Buy |
638,349
+309,540
| +94% | +$18.7M | 0.07% | 213 |
|
|
2019
Q1 | $21M | Buy |
328,809
+310,965
| +1,743% | +$17.7M | 0.03% | 400 |
|
|
2018
Q4 | $911K | Sell |
17,844
-80,307
| -82% | -$4.06M | ﹤0.01% | 2703 |
|
|
2018
Q3 | $5.7M | Buy |
98,151
+24,288
| +33% | +$1.19M | 0.01% | 946 |
|
|
2018
Q2 | $3.58M | Buy |
+73,863
| New | +$3.45M | 0.01% | 1332 |
|
|
2018
Q1 | – | Sell |
-32,418
| Closed | -$1.41M | – | 4937 |
|
|
2017
Q4 | $1.22M | Buy |
32,418
+9,906
| +44% | +$364K | ﹤0.01% | 2117 |
|
|
2017
Q3 | $820K | Sell |
22,512
-38,151
| -63% | -$1.46M | ﹤0.01% | 2504 |
|
|
2017
Q2 | $2.39M | Buy |
60,663
+48,309
| +391% | +$1.76M | 0.01% | 1331 |
|
|
2017
Q1 | $387K | Sell |
12,354
-162,087
| -93% | -$5.07M | ﹤0.01% | 3154 |
|
|
2016
Q4 | $5.45M | Buy |
174,441
+37,023
| +27% | +$1.2M | 0.02% | 607 |
|
|
2016
Q3 | $5.52M | Buy |
137,418
+81,000
| +144% | +$3.05M | 0.03% | 548 |
|
|
2016
Q2 | $1.88M | Sell |
56,418
-24,144
| -30% | -$826K | 0.01% | 1333 |
|
|
2016
Q1 | $2.37M | Buy |
80,562
+46,644
| +138% | +$1.29M | 0.01% | 1037 |
|
|
2015
Q4 | $893K | Buy |
33,918
+17,616
| +108% | +$457K | 0.01% | 1867 |
|
|
2015
Q3 | $386K | Buy |
+16,302
| New | +$393K | ﹤0.01% | 2551 |
|
|
2015
Q2 | – | Sell |
-27,060
| Closed | -$611K | – | 3726 |
|
|
2015
Q1 | $642K | Buy |
+27,060
| New | +$607K | 0.01% | 1790 |
|
|
2014
Q4 | – | Sell |
-29,388
| Closed | -$500K | – | 2614 |
|
|
2014
Q3 | $500K | Sell |
29,388
-33,864
| -54% | -$535K | 0.01% | 1444 |
|
|
2014
Q2 | $905K | Sell |
63,252
-380,568
| -86% | -$5.16M | 0.01% | 972 |
|
|
2014
Q1 | $5.49M | Buy |
+443,820
| New | +$5.12M | 0.06% | 226 |
|
Other funds holding EW
VCM
VPM
Jane Street's EW Position: Q1 2026 in Review
Jane Street reduced its Edwards Lifesciences (EW) stake by 34% in Q1 2026, selling an estimated $16.6M and leaving 390,333 shares worth $31.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1407.
Jane Street first reported a position in EW in Q1 2014 and has held it in 45 quarters since. The position peaked at $121M in Q3 2025. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Jane Street held 390,333 shares of Edwards Lifesciences worth $31.3M as of Q1 2026.
- Jane Street sold 201,167 Edwards Lifesciences shares in Q1 2026, an estimated $16.6M.
- Edwards Lifesciences made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #1407 holding.
- Jane Street first reported a position in Edwards Lifesciences in Q1 2014 and has held it in 45 quarters since.
- Jane Street's Edwards Lifesciences position peaked at $121M in Q3 2025.
- 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.